Nuova Casa di Cura
Nuova Casa di Cura is a private, SSN-accredited multidisciplinary hospital in Decimomannu, Sardinia, offering surgery, diagnostics, dialysis, and rehabilitation across 14+ units to public and private patients in southern Sardinia.
- Company typePrivate
- Founded1993
- HeadquartersDecimomannu, Italy
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Nuova Casa di Cura does
Nuova Casa di Cura S.r.l. is a private, multidisciplinary healthcare facility founded in 1993 and headquartered in Decimomannu, Sardinia (with legal seat in Cagliari). It operates 14+ clinical units covering general and minimally invasive surgery (notably thyroid surgery), orthopedics, urology, gynecology, ophthalmology, otorhinolaryngology, internal medicine, oncology, cardiology, nephrology and dialysis, rehabilitation, diagnostic imaging, digestive endoscopy, and clinical laboratory analysis. The facility is accredited with the Italian National Health Service (SSN) and serves as a regional reference point for southern Sardinia spanning Sulcis-Iglesiente, Guspinese, and Medio Campidano.
The facility is equipped with advanced imaging technology installed in 2018, including a GE SIGNA Voyager 1.5T MRI with SilentWorks and FreedomWorks technologies, a GE Revolution EVO 128-slice CT scanner delivering over 80% radiation dose reduction versus legacy systems, Hologic 3D tomosynthesis mammography, and 3D ABVS volumetric breast ultrasound. It has been accredited by the Società Italiana delle Unità di Endocrinochirurgia (SIUEC) as a Regional Center for Thyroid Surgery, with 4,000+ thyroidectomies performed cumulatively, including 1,200 minimally invasive MIVAT procedures in routine use since 2004.
Revenue is generated through three channels: SSN-reimbursed accredited services, private outpatient consultations and procedures, and a growing portfolio of preventive check-up packages priced between €25-€60. Distribution is dual-channel: in-person at the Decimomannu facility and through a digital self-service layer comprising a 24/7 online booking portal (servizionline.nuovacasadicura.eu), a free mobile app on iOS and Android, and integration with the Sardinia Region's Electronic Health Record (Fascicolo Sanitario Elettronico) for laboratory results since January 2024. The company's leadership includes Dr. Salvatore Floris (Medical Director), Dr. Alberto Loi (Legal Representative since June 2026), and dedicated department heads across each clinical unit. No parent company, external investor, or public funding is disclosed; the entity operates as a privately held Società a responsabilità limitata with €200,000 subscribed share capital and 51-100 employees.
Nuova Casa di Cura firmographics
Firmographics- Name
- Nuova Casa di Cura
- Legal name
- Nuova Casa di Cura S.r.l.
- Website
- https://nuovacasadicura.eu
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Nuova Casa di Cura is a private, SSN-accredited multidisciplinary hospital in Decimomannu, Sardinia, offering surgery, diagnostics, dialysis, and rehabilitation across 14+ units to public and private patients in southern Sardinia.
- Ownership category
- akta.pro rank
Where Nuova Casa di Cura is headquartered
LocationHeadquarters
- HQ city
- Decimomannu
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
Nuova Casa di Cura business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- National Health Service (SSN) Reimbursements: Accredited private healthcare facility providing services reimbursed by the Italian National Health Service. Patients access services through the public healthcare system with SSN coverage.
- Private Outpatient Services: Private medical consultations and procedures for patients paying out-of-pocket or through private insurance. Services include specialist visits, diagnostic imaging, and surgical procedures.
- Laboratory Analysis Services: Clinical laboratory testing services available both through SSN and privately, including specialized check-up packages
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Check Young - Basic health screening for young adults |
| Unit Pricing | Pay-as-you-go | Check Man (over 65) - Comprehensive male health screening |
| Unit Pricing | Pay-as-you-go | Check Woman (over 65) - Comprehensive female health screening |
| Unit Pricing | Pay-as-you-go | Cardiovascular Check - Heart health assessment |
| Unit Pricing | Pay-as-you-go | Diabetes Check - Diabetic monitoring package |
| Unit Pricing | Pay-as-you-go | Thyroid Check - Thyroid function assessment |
| Unit Pricing | Pay-as-you-go | Osteoporosis Check - Bone health screening |
| Unit Pricing | Pay-as-you-go | Vegetarian Check - Nutritional assessment for vegetarians |
| Unit Pricing | Pay-as-you-go | Colon Tumor Check - Colorectal cancer screening |
| Unit Pricing | Pay-as-you-go | Molecular COVID-19 Test (RT-PCR) |
| Unit Pricing | Pay-as-you-go | Serological COVID-19 Test (Ig total) |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Nuova Casa di Cura product offering
Product offeringCore offering
Nuova Casa di Cura is a multidisciplinary, SSN-accredited private hospital in Decimomannu, Sardinia, providing inpatient and outpatient healthcare services through 14+ operational units spanning general surgery (including minimally invasive thyroidectomy), urology, orthopedics, gynecology, otolaryngology, ophthalmology, oncology, cardiology, dialysis, rehabilitation, general medicine, and digestive endoscopy. The facility operates advanced diagnostic imaging (1.5T MRI, 128-slice CT, 3D mammography) and a clinical laboratory, supplemented by a 24/7 online services portal for booking, report delivery, and patient engagement.
Product overview
Nuova Casa di Cura is a private healthcare facility in Decimomannu, Sardinia, offering a comprehensive range of medical services through multiple operational units. The facility provides both inpatient and outpatient services, combining traditional medical treatments with advanced diagnostic technology. The product portfolio includes: a digital services platform (Servizi On-Line) enabling online appointments, report downloads, and mobile app access; advanced diagnostic imaging services featuring GE MRI (1.5T), 128-slice CT, 3D tomosynthesis mammography, and breast MRI; comprehensive surgical services including general surgery with minimally invasive thyroidectomy (MIVAT), urology, orthopedics, and ophthalmology; medical departments covering dialysis, rehabilitation, oncology, cardiology, otorhinolaryngology, gynecology, and digestive endoscopy; clinical laboratory services with online result delivery; and preventive health screening packages. The facility operates as a multidisciplinary healthcare center accredited with the Italian National Health Service (SSN), serving patients across southern Sardinia including Sulcis-Iglesiente, Guspinese, and Medio Campidano regions.
Differentiator
Problem solved
Functional benefit
Products and services
- General Surgery (Chirurgia Generale) Surgical department offering conventional and minimally invasive procedures, including MIVAT (minimally invasive video-assisted thyroidectomy) with approximately 4,000 thyroidectomies performed and 1,200 minimally invasive procedures.
- Urology Urological surgery and treatment services provided through the dedicated urology unit.
- Orthopedics and Traumatology Orthopedic surgery and traumatology services for musculoskeletal conditions and injuries.
- Rehabilitation Rehabilitation services delivered by physiotherapy and physical medicine specialists.
- Gynecology Gynecological services including breast health monitoring and routine gynecological care.
- Otolaryngology (ENT) Ear, nose, and throat specialty services for ENT conditions.
- Ophthalmology Eye care and ophthalmological surgical services.
- Dialysis Center Dialysis treatment services including arteriovenous fistula monitoring for dialysis patients.
- Fistula Control (Controllo Fistole) Dedicated unit for monitoring and management of arteriovenous fistulas used in hemodialysis access.
- Diagnostic Imaging Comprehensive imaging services including MRI, CT, mammography, ultrasound, color Doppler, traditional radiology, and breast MRI.
- Digestive Endoscopy Gastrointestinal endoscopy services for diagnostic and therapeutic procedures.
- Laboratory Analysis Clinical laboratory testing services with online report delivery, including SARS-CoV-2 molecular RT-PCR testing and serological tests.
- Cardiology Cardiology services including cardiac diagnostics and monitoring.
- Oncology Oncology department treating breast, gastrointestinal, lung, genitourinary, and brain tumors, providing chemotherapy, biological therapies, and supportive care.
- General Medicine General medicine department providing integrated multidisciplinary inpatient and outpatient care.
- Pain Therapy (Terapia del Dolore) Pain therapy service for recognition, evaluation, and treatment of chronic pain conditions.
- Skin and Subcutaneous Tissue Surgery (Chirurgia della Cute e dei Tessuti Sottocutanei) Plastic, reconstructive, and aesthetic surgery service for skin and subcutaneous tissue conditions, led by Dr. Pietro Serra.
- Preventive Health Check-up Packages Predefined laboratory screening packages including Check Young (EUR 25), Check Man over 65 (EUR 60), Check Woman over 65 (EUR 60), Cardiovascular Check (EUR 40), Diabetes Check (EUR 40), Thyroid Check (EUR 60), Osteoporosis Check (EUR 40), Vegetarian Check (EUR 50), and Colon Cancer Check (EUR 25).
- Online Services Portal (Servizi On-Line) Digital platform enabling patients to book appointments online, consult and download medical reports, and request information, available 24/7 with integration to the Sardinia regional Electronic Health Record.
Quantifiable outcome
- Over 80% radiation dose reduction with GE Revolution EVO CT compared to traditional technology
- +2 more outcomes
Companies that use Nuova Casa di Cura
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Nuova Casa di Cura technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Nuova Casa di Cura partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- AVIS (Associazione Volontari Italiani del Sangue) - DecimomannuminorBlood donation collaboration with AVIS Decimomannu for organizing blood collection drives. First collection held December 21 with 23 blood units collected. Initiative planned to repeat at least twice yearly to address generational gap in blood donors.
- Lions Club Cagliari HostminorJoint organization of first aid course for medical emergencies, held at Banco di Sardegna conference hall. Multiple Nuova Casa di Cura staff members participated as speakers/trainers.
- GAPO Servizi / ConfindustriaminorTraining program facilitators that helped design and implement the 2024 group work training program funded through Fondimpresa, involving 19 collaborators.
- General Electric (GE) HealthcarecoreEquipment provider supplying advanced medical imaging technology including GE SIGNA Voyager 1.5T MRI and GE Revolution EVO 128-slice CT scanner, installed in 2018.
- Regione Sardegna - SanitàcoreRegional health authority providing Electronic Health Record (FSE) system integration. Laboratory results are automatically sent to patient Fascicolo Sanitario Elettronico.
- CTM (Consorzio Trasporti e Mobilità) CagliariminorPublic transportation company that expanded Line 9 bus service to reach the healthcare facility directly, improving accessibility for patients.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Nuova Casa di Cura competitors and assessment
Company assessmentDirect peers
- Istituto Auxologico Italiano: Italian IRCCS network of SSN-accredited hospitals focused on cardiology, neurology, endocrinology and rehabilitation. Comparable to Nuova Casa di Cura as a multispecialty SSN-accredited private operator with a strong endocrinology/surgery alignment (relevant to the thyroid franchise) and similar community-hospital scale.
- MultiMedica: Italian private hospital group (MultiMedica) operating SSN-accredited facilities in Lombardy with multispecialty services and advanced diagnostics. Comparable to Nuova Casa di Cura as a regional Italian private accredited provider, with broader geographic coverage but a similar multispecialty general-hospital profile.
- Istituto Europeo di Oncologia (IEO): Private specialty oncology hospital in Milan, fully SSN-accredited, focused on cancer treatment and research. Comparable to Nuova Casa di Cura's oncology department and broader specialty-surgery model as an SSN-accredited private specialty provider in Italy.
Broad incumbents
- Humanitas: Major Italian private hospital and university group with multiple SSN-accredited facilities (Humanitas Research Hospital, Humanitas Gavazzeni, etc.). Comparable as a multispecialty SSN-accredited private operator with advanced diagnostic imaging and integrated digital services, but with a national footprint Nuova Casa di Cura does not have.
- Ospedale San Raffaele: Large IRCCS research and multispecialty hospital in Milan, part of Gruppo San Donato. Comparable to Nuova Casa di Cura as an SSN-accredited multispecialty hospital, but operates at academic-medical-centre scale with significantly broader research and specialty depth.
- Policlinico Universitario Agostino Gemelli: Large Catholic-university-affiliated multispecialty hospital in Rome with SSN accreditation. Comparable as a multispecialty Italian hospital offering surgery, oncology, diagnostics and rehabilitation at scale, with a research/teaching orientation Nuova Casa di Cura does not have.
- Gruppo San Donato: Italy's largest private hospital group, operating numerous accredited clinics and hospitals nationwide including IRCCS San Raffaele. Comparable to Nuova Casa di Cura as an SSN-accredited Italian private healthcare provider, but at a substantially larger scale and broader geographic footprint.
Emerging players
- Santagostino: Italian private outpatient diagnostic and specialist network (based in Lombardy) with strong digital booking and self-pay model. Comparable to Nuova Casa di Cura on the digital-services portal and online-check-up-package proposition, though focused on outpatient diagnostics rather than inpatient hospital care.
Regional players
- AOU Cagliari (Policlinico Universitario di Cagliari): Public university hospital located in Cagliari, the main public multispecialty competitor in Nuova Casa di Cura's core catchment. Comparable in service-line breadth (surgery, diagnostics, oncology, etc.) but operates as a public teaching hospital rather than a private accredited facility.
- ARNAS Brotzu: Large public hospital trust in the Cagliari metropolitan area covering emergency, surgery, oncology and diagnostics. Directly competes with Nuova Casa di Cura for SSN-funded patients in the same Sardinian geography, but at significantly larger public-hospital scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Nuova Casa di Cura social profiles
Digital presenceNuova Casa di Cura financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nuova Casa di Cura leadership team
Management profileNumber of profiles
Profiles9 records
Nuova Casa di Cura funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nuova Casa di Cura M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nuova Casa di Cura
What does Nuova Casa di Cura do?
Nuova Casa di Cura is a multidisciplinary, SSN-accredited private hospital in Decimomannu, Sardinia, providing inpatient and outpatient healthcare services through 14+ operational units spanning general surgery (including minimally invasive thyroidectomy), urology, orthopedics, gynecology, otolaryngology, ophthalmology, oncology, cardiology, dialysis, rehabilitation, general medicine, and digestive endoscopy. The facility operates advanced diagnostic imaging (1.5T MRI, 128-slice CT, 3D mammography) and a clinical laboratory, supplemented by a 24/7 online services portal for booking, report delivery, and patient engagement.
Is Nuova Casa di Cura a public or private company?
Nuova Casa di Cura is a private company. It is classified as family owned and is currently operating.
When was Nuova Casa di Cura founded?
Nuova Casa di Cura was founded in 1993. It employs 51 to 100 people.
Where is Nuova Casa di Cura based?
Nuova Casa di Cura is headquartered in Decimomannu, Italy, in the Europe region.
How does Nuova Casa di Cura make money?
Three revenue lines are on record. National Health Service (SSN) Reimbursements are the primary driver. The others are private Outpatient Services and laboratory Analysis Services.
Who are Nuova Casa di Cura's main competitors?
Direct peers on record are Istituto Auxologico Italiano, MultiMedica and Istituto Europeo di Oncologia (IEO). Broad incumbents are Humanitas, Ospedale San Raffaele, Policlinico Universitario Agostino Gemelli and Gruppo San Donato. Santagostino is listed as an emerging player. Regional players are AOU Cagliari (Policlinico Universitario di Cagliari) and ARNAS Brotzu.
Does Nuova Casa di Cura have an API?
No public API is recorded for Nuova Casa di Cura.